QQ客服 官方微博 反馈留言

	Concurrent chemoradiotherapy with weekly docetaxel and cisplatin versus docetaxel and nedaplatin for locally advanced esophageal carcinoma
	Lu, Chunhui; Liang, Ning; Hu, Pingping; Zhang, Jiandong; Zhang, Xuede; Liu, Yuanshui; Lu, Chunxiao
刊名	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
	2018
卷号	11期号:8页码:8382-8391
关键词	Esophageal squamous cell carcinoma chemoradiotherapy intensity-modulated radiotherapy nedaplatin locally advanced
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4581720
专题	山东大学
作者单位	1.Taishan Med Univ, Dept Oncol, Tai An, Shandong, Peoples R China. 2.Shandong Univ, Dept Rad
推荐引用方式 GB/T 7714	Lu, Chunhui,Liang, Ning,Hu, Pingping,et al. Concurrent chemoradiotherapy with weekly docetaxel and cisplatin versus docetaxel and nedaplatin for locally advanced esophageal carcinoma[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2018,11(8):8382-8391.
APA	Lu, Chunhui.,Liang, Ning.,Hu, Pingping.,Zhang, Jiandong.,Zhang, Xuede.,...&Lu, Chunxiao.(2018).Concurrent chemoradiotherapy with weekly docetaxel and cisplatin versus docetaxel and nedaplatin for locally advanced esophageal carcinoma.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,11(8),8382-8391.
MLA	Lu, Chunhui,et al."Concurrent chemoradiotherapy with weekly docetaxel and cisplatin versus docetaxel and nedaplatin for locally advanced esophageal carcinoma".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 11.8(2018):8382-8391.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。